Strategien zur Verbesserung der Therapietreue bei antihypertensiver Therapie

Therapietreue - Compliance - arterielle Hypertonie

compliance - adherence - arterial hypertension

Literatur

• 1 Bloom B S. Continuation of initial antihypertensive medication after 1 year of therapy.  Clin Ther. 1998;  20 671-681
• 2 Burke T A, Sturkenboom M C, Lu S L, Wentworth C E, Lin Y, Rhoads G G. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.  J Hypertens. 2006;  24 1193-1200
• 3 Caro J J, Salas M, Speckman J L, Raggio G, Jackson J D. Persistence with treatment for hypertension in actual practice.  Can Med Assoc J. 1999;  160 31-37
• 4 Conlin P R, Gerth W C, Fox J, Roehm J B, Boccuzzi S J. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist Losartan versus other antihypertensive drug classes.  Clin Ther. 2001;  23 1999-2010
• 5 Dahlof B, Sever P S, Poulter N R. ASCOT Investigators . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).  Lancet. 2005;  366 895-906
• 6 Düsing R. Medikamentöse Therapie mit verblisterten Arzneimitteln: Möglichkeiten und Chancen.  MMW-Fortschritte der Medizin Originalien. Nr. I/2007;  149 9-20
• 7 Düsing R. Therapietreue bei medikamentöser Behandlung.  Dtsch Med Wochenschr. 2006;  131 H28-30
• 8 http://www.aardexgroup.com/index.php. 18.10.07. 
• 9 http://www.assist-pharma.de/index.php. 18.10.07. 
• 10 Metry J M, Meyer U A. Drug Regimen Compliance: Issues in Clinical Trials and Patient Management. John Wiley & Sons Chichester 1999
• 11 SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP).  J Am Med Assoc. 1991;  265 3255-3264
• 12 The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group . Major outcomes in high-risk hypertensiven patients radndomized to angiotensin-converting-enzyme inhibitor or calcium channel blocker vs diuretic.  J Am Med Assoc. 2002;  288 2981-2997
• 13 Urquhart J, Vrijens B. Introduction to pharmionics: the vagaries in ambulatory patients’ adherence to prescribed drug dosing regimens and some of their clinical and economic consequences.  In: Mann RD, Andrews EB Pharmacovigilance, 2nd ed. John Wiley & Sons Chichester 2007
• 14 Urquhart J, Vrijens B. Patient adherence to prescribed drug dosing regimens in ambulatory pharmacotherapy.  In: Strom BL, Kimmel SE Textbook of Pharmacoepidemiology. John Wiley & Sons Chichester 2006
• 15 Urquhart J. Patient compliance with prescribed drug regimens: overview of the past 30 years of research.  In: Nimmo WS, Tucker GT Clinical Measurement in Drug Evaluation. John Wiley & Sons Chichester 1995: 213-227
• 16 Urquhart J. The electronic medication event monitor - lessons for pharmacotherapy.  Clin Pharmacokinet. 1997;  32 345-356